Charles River Laboratories (CRL) Tops Q2 EPS by 40c; lowers guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $286.64 +2.35%
Financial Fact:
Operating income: 58.8M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Operating income: 58.8M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $2.80, $0.40 better than the analyst estimate of $2.40. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1.02 billion.
GUIDANCE:
Charles River Laboratories sees FY2024 EPS of $9.90-$10.20, versus the consensus of $10.99.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Textron Systems wins $231 million Navy contract for landing craft
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
